Martin B. Wax M.D. is currently the Chief Medical Officer and Executive Vice-President of R&D at PanOptica, Inc., a private biotechnology company specializing in ophthalmic pharmaceuticals. He was Vice President of R&D and Head of Ophthalmology Discovery Research and Preclinical Sciences at Alcon Laboratories in Ft. Worth, Texas from 2003-2008. He is currently a Clinical Professor of Ophthalmology and Visual Sciences at the Rutgers Medical School in Newark, NJ. Dr. Wax received his medical degree from the University of Southern California in Los Angeles. He completed his residency in Ophthalmology at Wills Eye Hospital in Pennsylvania, and was a postdoctoral fellow first in Neuropharmacology and then in Glaucoma at the University of Pennsylvania School of Medicine in Philadelphia. Prior to entering industry as the head of Ophthalmology Research at Pharmacia Corporation in 2002, he held the distinguished Research to Prevent Blindness Chair as a Professor of Ophthalmology at Washington University School of Medicine in St. Louis, MO.
He has coauthored more than 200 publications including peer-reviewed articles, abstracts and chapter in books and is an internationally recognized scientific expert in the field of glaucoma and ocular pharmacology. Dr. Wax was the recipient of the 1991 Robert E. McCormick Scholarship and the 1995 Lew R. Wasserman Merit Award for his contributions to basic eye research, the 1999 Rudin Prize from the NY Academy of Medicine, the 2001 Senior Investigator Award from Research to Prevent Blindness, the 2003 Clinician-Scientist Award from the American Glaucoma Society and the 2010 Barany Prize in Ocular Pharmacology from ISER. He is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology and the American Glaucoma Foundation. He currently serves on several national and international Scientific Advisory Committees, Editorial Boards, and corporate Boards.
Find your profile and take control of your online presence: